scispace - formally typeset
F

Fabrizio De Rita

Researcher at Freeman Hospital

Publications -  19
Citations -  512

Fabrizio De Rita is an academic researcher from Freeman Hospital. The author has contributed to research in topics: Ventricular assist device & Medicine. The author has an hindex of 9, co-authored 13 publications receiving 315 citations. Previous affiliations of Fabrizio De Rita include Newcastle upon Tyne Hospitals NHS Foundation Trust.

Papers
More filters
Journal ArticleDOI

A cell atlas of human thymic development defines T cell repertoire formation.

TL;DR: The authors' single-cell transcriptome profile of the thymus across the human lifetime and across species provides a high-resolution census of T cell development within the native tissue microenvironment, and identifies novel subpopulations of human thymic fibroblasts and epithelial cells and located them in situ.
Journal ArticleDOI

Mechanical cardiac support in children with congenital heart disease with intention to bridge to heart transplantation

TL;DR: Children with CHD can be successfully bridged with MCS to heart transplantation, and single-ventricle circulation compared with biventricular physiology does not increase the risk of death before transplant or before hospital discharge.
Journal ArticleDOI

Outcome following heart transplant assessment in adults with congenital heart disease.

TL;DR: The outcomes of ACHD patients undergoing assessment for orthotopic heart transplant (OHT) are described to describe the outcomes of patients who are unsuitable or too high risk and those who are considered too well for listing.
Journal ArticleDOI

Management of the failing Fontan.

TL;DR: The magnitude of the disease, the physio-pathological mechanisms, and the therapeutic options to optimize the "failing Fontan" status and to delay the irreversible deterioration of "Fontan failure" condition are discussed in this review.
Journal ArticleDOI

Comparison of paracorporeal and continuous flow ventricular assist devices in children: preliminary results.

TL;DR: Early experience with the CF intracorporeal LVAD system (HVAD) indicates outcomes comparable to those with the well-established pulsatile flow paracorpaneous LVAD (BH), and the theoretical durability of the CF device is yet to be proven.